Persistent loss of IL-27 responsiveness in CD8<sup>+</sup> memory T cells abrogates IL-10 expression in recall response by Perona-Wright, G. et al.
Persistent loss of IL-27 responsiveness in CD8+
memory T cells abrogates IL-10 expression in
a recall response
Georgia Perona-Wrighta,b,1,2, Jacob E. Kohlmeiera,3, Elizabeth Bassitya, Tori C. Freitasa,4, Katja Mohrsa,
Tres Cookenhama, Haozhong Situb, Edward J. Pearcea,5, David L. Woodlanda,6, and Markus Mohrsa,1
aTrudeau Institute, Saranac Lake, NY 12983; and bDepartment of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada V6T 1Z3
Edited by Susan M. Kaech, Yale University School of Medicine, New Haven, CT, and accepted by the Editorial Board October 2, 2012 (received for review
November 20, 2011)
CD8+ T cells are central to the eradication of intracellular patho-
gens, but they can also act to limit inflammation and immunopa-
thology. During primary respiratory viral infection CD8+ effector T
cells release the immunosuppressive cytokine IL-10, which is essen-
tial for host survival. Here we report that CD8+ T-cell–derived IL-10
is absent in a recall response. We show in mice that the lack of IL-10
is due to a persistent loss of IL-27 responsiveness in CD8+ memory
T cells, caused by down-regulation of the common cytokine recep-
tor, glycoprotein 130. CD8+memory T cells secreted less IL-10 when
activated in the presence of IL-27 than did naïve controls, and ret-
roviral expression of glycoprotein 130 restored IL-10 and reduced
IFN-γ production upon restimulation. We demonstrate that human
CD8+memory cells are also characterized by impaired IL-27 respon-
siveness. Our data suggest that CD8+ T-cell activation involves
a persistent loss of specific cytokine receptors that determines the
functional potential of these cells during rechallenge infection.
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Immunological memory is the ability of the immune system torecognize a pathogen that it has encountered previously and to
mount a faster and more effective response upon subsequent
exposure (1). The strength of the recall response reflects both
quantitative and qualitative changes in lymphocyte populations.
Following infection with respiratory influenza or parainfluenza
viruses, high frequencies of virus-specific CD8+ T cells persist
many months after virus is cleared (2, 3). These CD8+memory T
cells have a lower activation threshold, more rapidly acquire
effector functions, and can preferentially localize to infected tis-
sues, compared with naïve CD8+ cells (4–6). Their presence means
that, during a rechallenge infection, viral clearance is accelerated
and mice are able to survive otherwise lethal doses of virus (7, 8).
In a primary infection the strength of the effector response is
tempered by a need to limit collateral damage. Interleukin (IL)-10
is an important mediator of this balance (9). IL-10–deficient mice
infected with Toxoplasma gondii control pathogen replication more
efficiently than wild-type controls but succumb to fatal immuno-
pathology (10, 11). The primary immune response to influenza virus
also features IL-10, expressed by highly activated CD8+ effector T
cells, and essential to prevent lethal pulmonary inflammation (12).
In Leishmania major infection, IL-10 dampens the immune re-
sponse, prevents sterile clearance of the parasite, and leads to long-
term symbiosis (13, 14). IL-10 is also implicated in the persistence
of chronic lymphocytic choriomeningitis virus (15, 16).
The importance of IL-10 during a recall response remains
controversial. Because activated effector T cells are a prominent
source of IL-10 during primary infection (12, 14, 17), the exag-
gerated T-cell expansion of a secondary response might be pre-
dicted to amplify IL-10 production. It could equally be argued,
however, that the enhanced ability of a secondary immune re-
sponse to clear the invading pathogen is evidence of reduced
immunosuppression and less IL-10. To distinguish these possibil-
ities, we analyzed IL-10 expression during primary and secondary
respiratory viral infections. We observed a marked deficiency in
IL-10+ CD8+ effector T cells during the recall response. The
induction of IL-10 during primary viral infection was dependent
on direct IL-27 signaling, and we demonstrate that its absence
from the memory response is due to a persistent loss of IL-27
responsiveness caused by down-regulation of the common cyto-
kine receptor chain, glycoprotein 130 (gp130). Together our data
reveal that CD8+ T-cell differentiation involves distinct changes
in cytokine responsiveness that dictate the functional charac-
teristics of these cells during a recall response.
Results
CD8+ Memory Response to Rechallenge Is Deficient in IL-10. To in-
vestigate changes in cytokine expression and cytokine re-
sponsiveness during T-cell differentiation in vivo, we infected
WT and GFP/IL-10 reporter mice [Vert-X mice (12, 18)] with
the respiratory influenza or Sendai viruses and followed the
development of endogenous, antigen-specific effector and
memory populations. Primary infection with either virus elicited
a robust expansion of antigen-specific CD8+ effector cells in the
airways (Fig. 1 A and C) and lungs (Fig.1 B and C). A subset of
these effector cells expressed the immunoregulatory cytokine IL-
10 (Fig. 1 A–C), consistent with data from Braciale and co-
workers (12). IL-10 expression was greatest 10 d after infection
with either influenza or Sendai virus, corresponding with peak
expansion of antigen-specific CD8+ effector cells (Fig. 1D). At
this time the majority of antigen-specific CD8+ cells, including
the IL-10+ subset, also expressed the Th1-associated transcrip-
tion factor T-bet (Fig. S1). IL-10 expression returned to baseline
by 15 d postinfection and remained low at 45 d (Fig. 1D).
To determine whether secondary CD8+ effector T cells also
express IL-10, we infected Vert-X mice with PR8 influenza virus
(H1N1) and, 30–35 d later, challenged with the heterosubtypic ×31
influenza virus strain (H3N2). Control animals were initially sham-
infected and subsequently received the ×31 challenge dose as
a primary infection. IL-10 expression was clearly induced in primary
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antigen-specific CD8+ T cells in response to ×31 virus but was
strikingly reduced when the same ×31 challenge was delivered as
a second infection (Fig. 2A and Fig. S2). The reduced IL-10 ex-
pression during the recall response was evident on days 5, 6, and 8
after the challenge infection (Fig. S3) and was common to CD8+
cells specific for both the NP and PA epitopes of the influenza virus
(Fig. 2A), suggesting that the IL-10 deficiency was independent of
antigen specificity (19). Both primary and secondary CD8+ cells
expressed CD69 at a similar frequency, which indicated that the
loss of IL-10 in the recall response occurred despite equivalent
cellular activation (Fig. 2B). The lack of IL-10 during rechallenge
also occurred irrespective of the different immunodominance of
primary and secondary responses (Fig. 2C) (19).
IL-10 Expression in CD8+ T Cells Requires Direct IL-27 Signaling. To
investigate the mechanism responsible for decreased IL-10 ex-
pression in a secondary viral infection, we first sought to establish
the factors required for IL-10 induction during the primary T-
cell response. Several recent publications have reported a role
for IL-27 in eliciting IL-10 production by CD8+ lymphocytes
(20–22), and we tested whether this was also the case during
respiratory viral infection. We generated mixed bone marrow
chimeras reconstituted with equal parts of WT and IL-27Rα−/−
(23) congenic bone marrow. This approach allowed us to com-
pare WT and IL-27 receptor-deficient cells within the same an-
imal and thus exposed to the same environment. When these
mice were infected with Sendai virus, only the WT and not the
IL-27R–deficient antigen-specific CD8+ T cells induced IL-10
(Fig. 3A). The expansion of Sendai-specific CD8+ cells upon
infection was also compromised in the absence of the IL-27R
(Fig. 3B), consistent with previous data (24) and amplifying the
overall deficit in IL-10 expression. In vitro, the ability of IL-27 to
promote IL-10 expression was independent of its effect on cell
proliferation; IL-27Rα−/− cells failed to express IL-10 even at
division numbers that were IL-10+ in WT cells (Fig. 3C). Col-
lectively these data show that, during a primary respiratory viral
infection, direct IL-27 signaling is required for the induction of
IL-10 expression in antigen-specific CD8+ cells.
CD8+ Memory T Cells Show a Persistent Loss of IL-27 Responsiveness.
The dependence of IL-10 expression during a primary re-
spiratory viral infection on direct IL-27 signals suggested that the
absence of IL-10 in the CD8+ memory recall response could
reflect a defect in the ability of CD8+ memory T cells to respond
to IL-27. To test this hypothesis, we analyzed IL-27 re-
sponsiveness in resting CD8+ naïve and memory T cells. In
lymphocytes, IL-27 signals through the phosphorylation of
intracellular signal transducer and activator of transcription
(STAT) proteins 1 and 3, of which STAT3 has been particularly
associated with the induction of IL-10 (22, 25, 26). We harvested
splenocytes from WT C57BL/6 mice that had been infected with
either Sendai or influenza virus 30–50 d earlier, stimulated the
cells with IL-27, and assessed STAT3 and STAT1 phosphorylation
using flow cytometry. This approach allowed us to compare naïve
and memory CD8+ T cells from the same animal, exposed to
identical conditions and distinguished only by the gating strategy
used in analysis (Fig. 4A). Naïve CD44lo CD8+ lymphocytes
Fig. 1. CD8+ effector T cells express IL-10
in the lung and airways during respiratory
viral infection. (A) Vert-X IL-10 reporter
mice were infected intranasally with in-
fluenza ×31 or Sendai virus and, 10 d
later, cells in the bronchoalveolar lavage
(BAL) were analyzed by flow cytometry.
Infected nonreporter mice were analyzed
for comparison. Data shown are gated on
either total (left column) or CD8+ (right
column) lymphocytes. Numbers indicate
the percentage of cells within each quad-
rant. (B) Vert-X mice were infected as in A
and, 10 d later, lymphocytes from the lung
parenchyma were analyzed by flow cy-
tometry. Sham-infected Vert-X mice were
analyzed for comparison. (C) Vert-X mice
were infected with Sendai virus as in A and
on day 10 the indicated tissues were ana-
lyzed by flow cytometry. (D) Vert-X mice
were infected with Sendai virus as in A, and on days 0, 10, 15, and 45 postinfection the indicated tissues were analyzed by flow cytometry. In all panels, graphs
depict the mean ± SD of individual mice and all data are representative of at least two independent experiments using three to five mice per group.
Fig. 2. CD8+ T-cell–derived IL-10 is absent in a rechallenge infection. Vert-X
mice were sham-infected (1°) or infected with PR8 influenza virus (2°) and,
30–35 d later, challenged with ×31 influenza virus. Eight days after chal-
lenge, the indicated tissues were harvested and analyzed by flow cytometry.
(A) IL-10 expression; (B) CD69 expression; (C) frequency of influenza-specific
populations. All data are gated on CD8+ lymphocytes. Graphs indicate the
mean ± SD of individual mice and data are representative of four in-
dependent experiments with four or five mice per group.































responded to IL-27 with marked phosphorylation of STAT3 and
STAT1. In contrast, memory CD44hi CD8+ SenNP+ cells were
strikingly impaired in their IL-27 responsiveness (Fig. 4 A and
B). The reduction in STAT3 and STAT1 phosphorylation in
CD8+ memory T cells reflected a specific loss of IL-27 re-
sponsiveness, because IL-21 and IFNβ elicited robust phos-
phorylation of the corresponding STAT proteins in both naïve
and memory cells (Fig. 4C). The compromised IL-27 response in
antigen-specific CD8+ memory T cells was long-lasting, evident
in cells harvested from animals 11 mo after Sendai infection (Fig.
4D). Together these data reveal a profound and persistent loss of
IL-27 responsiveness in resting CD8+ memory T cells.
Human CD8+ Memory Cells Are Unresponsive to IL-27. To test
whether the loss of IL-27 responsiveness we observed in murine
memory CD8+ T cells is also a characteristic of human cells, we
obtained peripheral blood mononuclear cells (PBMC) from five
healthy HLA-A2+ human donors with reported ELIspot reactivity
to the influenza A M158–66 epitope (FluM1). Stimulation of these
PBMC samples with recombinant human IL-27 triggered STAT3
and STAT1 phosphorylation in naïve CD45RAhi CD27hi CD8+
lymphocytes, but to a much lesser extent in influenza-specific
CD45RAlo FluM1+ CD8+ memory T cells (Fig. 5 A and B). By
gating on unfractionated CD45RAlo memory CD8+ T lympho-
cytes, we demonstrated that the loss of IL-27 responsiveness is not
restricted to an influenza-specific subset but is common to the
bulk memory population (Fig. 5 A and C). These data show that,
like murine cells, human CD8+ memory lymphocytes display
a striking reduction in their ability to transmit IL-27 signals.
IL-27 Nonresponsiveness Reflects gp130 Down-Regulation. One ex-
planation for the persistent loss of IL-27 responsiveness in CD8+
memory T cells was a down-regulation of cytokine receptor
expression. The functional IL-27 receptor is a heterodimer
composed of an IL-27–specific cytokine binding chain (IL-27Rα,
also known as WSX-1 and TCCR) and a shared signaling com-
ponent, gp130 (27). Antibodies that recognize IL-27Rα were not
commercially available, so we determined its expression by pulsing
ice-cold cells with recombinant IL-27 and measuring bound cyto-
kine with a polyclonal anti–IL-27 antibody. The specificity of
staining was confirmed using IL-27Rα−/− cells (Fig. 6A). Both
naïve (CD44lo) and Sendai-specific memory (CD44hi SenNP+)
CD8+ lymphocytes from mice infected with Sendai virus 30–45 d
earlier displayed substantial levels of surface IL-27Rα, and the
difference between the two populations was modest (Fig. 6A). We
concluded that differential expression of IL-27Rα was unlikely to
explain the loss of IL-27 responsiveness in CD8+ memory T cells.
We next examined the other component of the heterodimeric
receptor, gp130. Surface gp130 was readily detectable on naïve
CD8+ CD44lo splenocytes from Sendai-immune C57BL/6 mice,
but not on Sendai-specific memory cells (CD44hi SenNP+) from
the same mice (Fig. 6B). Because gp130 is also a critical com-
ponent of the IL-6 receptor complex, the down-regulation of
gp130 on CD8+ memory cells predicted that this population
would also be unable to respond to IL-6. Indeed, when we in-
cubated splenocytes from Sendai-immune mice with recombinant
IL-6, STAT3 phosphorylation was markedly reduced in Sendai-
specific CD8+ memory cells compared with naïve CD44lo CD8+
cells (Fig. 6C). Corresponding expression of the IL-6 receptor α
chain was also reduced on virus-specific memory and effector CD8+
T cells, compared with their naïve counterparts (Fig. S4). Together
these data demonstrate that the cytokine response pattern of CD8+
memory T cells reflects marked changes in their cytokine receptor
repertoire, imposed during antigen-driven differentiation.
To investigate the kinetics of gp130 down-regulation, we first
examined gp130 expression on CD8+ effector cells in a primary
immune response. Ten days after influenza virus infection, virus-
specific CD8+ cells in both the lung and the spleen showed
Fig. 3. Direct IL-27 signaling is required for IL-10 expression. (A and B)
Mixed bone marrow chimeras comprising WT and IL-27Rα−/− Vert-X cells
were infected with Sendai virus and, 10 d later, cells from the bron-
choalveolar lavage (BAL) and lung were analyzed by flow cytometry. (A) IL-
10 expression; (B) frequency of Sendai-specific cells. (C) Naïve CD8+ T cells
from WT and IL-27Rα−/− Vert-X mice were labeled with a violet proliferation
dye, VPD450, and stimulated in vitro with anti-CD3 and anti-CD28 in the
presence or absence of recombinant IL-27. Cells were analyzed by flow
cytometry 3 d later. In all panels, data shown are gated on CD8+ lympho-
cytes and representative of three independent experiments. Graphs depict
mean ± SD of five mice per group.
Fig. 4. CD8+ memory T cells lose IL-27 responsiveness. (A and B) C57BL/6
mice were infected with Sendai virus and, 30–50 d later, splenocytes were
harvested, cultured with or without IL-27, and analyzed by flow cytometry.
(A) Representative histograms; (B) replicate data. (C) Splenocytes from
C57BL/6 mice infected with Sendai virus 30–50 d earlier were pulsed with or
without IL-21 or IFNβ and analyzed by flow cytometry. (D) C57BL/6 mice were
infected with Sendai virus and, 11 mo later, splenocytes were harvested,
cultured with or without IL-27, and analyzed by flow cytometry. In panels B–
D, data are gated on CD8+ naïve (CD44lo) or Sendai-specific memory
(CD44hi SenNP+) lymphocytes from the same spleen, as shown. Graphs de-
pict the mean fluorescence intensity (MFI) of pSTAT staining, and each data
point represents an individual mouse. All panels are representative of four
or five mice per group in two to five independent experiments.







































pronounced gp130 down-regulation (Fig. S5A). Naïve cells in the
same animal retained strong gp130 expression (Fig. S5A). We then
examined CD8+ T cells early after activation, by stimulating OT-I
T-cell receptor (TCR) transgenic cells in vitro with peptide-pulsed
antigen-presenting cells (APC). Antigen-activated transgenic cells
lost gp130 expression (Fig. S5B), consistent with published data
(28). The reduction in gp130 expression on stimulated CD8+ T
cells occurred progressively over a 3-d period, more slowly than
the rapid cellular activation revealed by CD44 up-regulation (Fig.
S5B). The gradual down-regulation of gp130 appears to provide
a time window immediately after antigen recognition in which
CD8+ T cells remain competent to receive IL-27 instruction.
Loss of IL-27 Signaling in CD8+ Memory T Cells Compromises IL-10
Production. To verify the physiological significance of gp130
down-regulation and loss of IL-27 responsiveness in CD8+
memory T cells, we sorted naïve (CD44lo CD62Lhi) and mem-
ory (CD44hi CD62Llo) CD8+ lymphocytes from the spleens of
individual WT C57BL/6 mice infected with Sendai virus 30–45 d
earlier and stimulated each population in the presence or ab-
sence of IL-27. The loss of IL-27 responsiveness in memory cells
resulted in a sharp reduction in IL-10 secretion, compared with
naïve cells (Fig. 7A). The IL-10 released by naïve cells was ac-
companied by a decrease in IFN-γ production, whereas the lack
of IL-10 expression by memory cells was consistent with equiv-
alent levels of IFN-γ production in the presence and absence of
IL-27 (Fig. 7A). Stimulation in the presence of IL-6 rather than
IL-27 elicited little IL-10 even from naïve cells (Fig. S6), con-
sistent with published data (22), and memory cells were equally
muted in response to either cytokine (Fig. S6).
To test whether the loss of IL-10 production by CD8+memory
T cells was a direct consequence of the down-regulation of
gp130, we wanted to compare memory cells that either did or did
not express gp130. We activated, transduced, and rested TCR
transgenic CD8+ cells in vitro, before restimulating them in the
presence or absence of recombinant IL-27. Preactivated trans-
genic cells transduced with an empty vector responded to
restimulation in a manner similar to that of pathogen-induced
CD8+memory cells: The presence of IL-27 made little difference
to either IL-10 or IFN-γ production (Fig. 7B). In contrast, ret-
roviral expression of gp130 resulted in the induction of IL-10 and
a corresponding reduction in IFN-γ release (Fig. 7B). These data
demonstrate that gp130 expression has a direct impact on the
cytokine balance shown by primary and secondary CD8+ effector
T cells. Collectively our findings reveal that CD8+ T-cell differen-
tiation involves distinct changes in cytokine responsiveness, enforced
by the regulation of specific cytokine receptors, that determine the
functional repertoire of these cells during a recall response.
Discussion
The differentiation of T cells into long-lasting memory pop-
ulations is a defining feature of adaptive immunity, and un-
derstanding this process is fundamental to the development of
effective vaccines. Our study reveals that, in comparison with their
naïve counterparts, CD8+ memory T cells show a profound and
sustained reduction in their ability to respond to IL-27. This loss of
IL-27 signaling is caused by down-regulation of surface gp130 and
results in a reduced capacity of CD8+ memory T cells to express
the immunosuppressive cytokine IL-10. We propose that CD8+
memory T cells are permanently altered in their ability to receive
cytokine instruction, through the differential expression of specific
cytokine receptors, and that this alteration in cytokine re-
sponsiveness defines their functional potential upon rechallenge.
Our data demonstrate a sustained loss of cytokine respon-
siveness in memory CD8+ T cells. Cytokine receptor expression
has previously been used to identify the precursors of memory T
cells: Following an acute systemic viral infection, the transition
from CD8+ effector cells into a long-lived memory cell has been
associated with differential expression of the IL-7 receptor (29),
and a similar argument has recently been made for IL-2Rα (CD25)
Fig. 5. Human CD8+ memory T cells show reduced responsiveness to IL-27.
Human PBMCs were obtained from healthy donors with reactivity to the
immunodominant influenza A M158–66 epitope (FluM1). Cells were cultured
with or without recombinant human IL-27 and analyzed by flow cytometry.
Naïve (CD45RAhi CD27hi), influenza virus-specific memory (FluM1+ CD45RAlo),
and total memory (CD45RAlo) CD8+ lymphocyte populations were defined
using the gating strategy shown. (A) Representative histograms. Graphs depict
the mean fluorescence intensity (MFI) of pSTAT staining in (B) naïve vs. in-
fluenza-specific memory and (C) naïve vs. total memory CD8+ populations.
Each data point represents an individual human donor.
Fig. 6. The loss of IL-27 re-
sponsiveness in CD8+ memory T cells
reflects gp130 down-regulation. (A)
C57BL/6 mice were infected with
Sendai virus and, 30–45 d later,
splenocytes were harvested and an-
alyzed by flow cytometry. Expression
of the IL-27Rα chain was assessed by
pulsing cells with recombinant IL-27
on ice and measuring bound cytokine with an anti-IL-27 Ab. Control cells were held on ice without IL-27 and otherwise stained identically. (B) Splenocytes
from C57BL/6 mice infected with Sendai virus 30–45 d earlier were stained with a gp130 mAb or an isotype-matched control (rat IgG2a) and analyzed by flow
cytometry. (C) Splenocytes from C57BL/6 mice infected with Sendai virus 30–45 d earlier were harvested, cultured with or without IL-6, and analyzed by flow
cytometry to assess STAT3 phosphorylation. In all panels, data are gated on CD8+ naïve (CD44lo) or Sendai-specific memory (CD44hi SenNP+) lymphocytes
from the same spleen. Graphs depict mean fluorescence intensity (MFI) and each data point represents an individual mouse. All panels are representative of
five mice per group in three or four independent experiments.































(30). In our study, we describe changes in cytokine responsiveness
that characterize steady-state CD8+ memory T cells and directly
affect CD8+ T-cell effector function during a recall response. We
show that the persistent loss of a functional IL-27 receptor on
CD8+ memory T cells is mediated not by reduced levels of IL-
27Rα but instead through down-regulation of the gp130 signal
transduction chain. These results are consistent with previous
observations of high IL-27Rα expression on memory cells (31)
and the ability of TCR engagement to reduce gp130 expression
on transgenic T cells in vitro (28). gp130 mediates cell signaling
for a family of cytokines that includes IL-27, IL-6, IL-11, leu-
kemia inhibitory factor, oncostatin M, and ciliary neurotrophic
factor (32). IL-6 is a proinflammatory factor that has been
reported to polarize the differentiation of T helper (Th) 2, Th17,
and cytotoxic T (Tc)17 T cells (33–36). T-cell polarization is
thought to be established during the activation of naïve lympho-
cytes and then stably maintained into memory (37), suggesting that
IL-6 signals may no longer be needed for this purpose in CD8+
memory cells. Interestingly, our data indicate that the reduced IL-6
responsiveness of CD8+ memory cells is less pronounced than
their loss of IL-27 signaling, despite the fact that gp130 is an
essential component of both receptors. We show that gp130
expression is reduced but not absent on CD8+ memory cells,
and our data therefore illustrate the different thresholds of re-
ceptor expression required for signal transduction in response to
discrete cytokines.
We show here that the loss of IL-27 responsiveness conferred
by gp130 down-regulation on CD8+ memory T cells abrogates
their IL-10 production during recall. Several recent reports have
described the ability of IL-27 to induce IL-10 in both autoim-
mune and infection models (20–22, 38–40). This has been pro-
posed to be an indirect effect, mediated via IL-21 (41), but our
comparison of WT and IL-27Rα−/− cells in chimeric animals
demonstrated an intrinsic requirement for IL-27 signaling in
eliciting IL-10 expression during respiratory virus infection. IL-27 is
released by APC in response to pathogen stimulation (38, 42).
We reported recently that cytokine signaling in vivo can be
pervasive, affecting the vast majority of cells within a reactive
lymph node (43). Such a model of indiscriminate cytokine sig-
naling emphasizes the importance of receptor regulation in en-
abling a cell to control its response to the cytokine environment.
The loss of a functional IL-27 receptor would override any var-
iation in exposure to IL-27.
In a primary infection the strength of the effector response is
tempered by a need to limit collateral damage, and in influenza
and other acute infections IL-10 plays an essential role in pre-
venting lethal immunopathology (10, 12). IL-10 can inhibit both
T-cell proliferation and IFN-γ production (9), and the reduced
IL-10 expression in the lung during a secondary influenza
infection that we and others have observed (44) is therefore
consistent with the prolific expansion and rapid effector differen-
tiation that characterize a recall response. During a primary in-
fluenza infection, however, IL-10 signaling is essential for
survival, and without it mice succumb to extensive pulmonary
inflammation (12). We report a marked reduction of IL-10 ex-
pression in CD8+ effector T cells during a rechallenge infection
with influenza virus, and yet the mice survive. Our model is that
the increased frequency and enhanced anti-viral potential of
antigen-specific CD8+ memory T cells enables a secondary im-
mune response, unimpeded by IL-10, to become effective more
quickly and to clear the pathogen at lower viral titers than those
of a naïve host (7, 8). The shorter duration of the secondary
immune response decreases the risk of immunopathology, neg-
ates the need for IL-10, and is reinforced by reduced IL-10 ex-
pression. This model predicts that whereas CD8-derived IL-10 is
host-protective in a primary infection (12), it is detrimental in
a recall response. We have shown that forced expression of
gp130 in CD8+ memory T cells restores IL-10 production, and it
will be interesting to test whether this change in cytokine po-
tential will inhibit the protective capacity of these cells in vivo.
Our data and those of Braciale and coworkers (12) illustrate
the dominance of CD8+ effector T cells within the IL-10+
population elicited by primary respiratory viral infection. Other
groups have also reported the ability of CD8+ T cells to express
IL-10 (45, 46) and, as in CD4+ lymphocytes (17), IL-10 pro-
duction correlates with CD8+ effector cells displaying the most
activated phenotype (12). This is consistent with the pre-
dominant localization of IL-10+ CD8+ cells in the infected tis-
sues and their concomitant expression of high levels of IFN-γ
(12, 47). Many other cell types have the capacity to produce IL-
10 during viral infection, including dendritic cells and CD4+
T cells (16, 44). CD8+ memory T cells remain IL-10–responsive
(48) and therefore able to be influenced by IL-10 from other
sources. It will be interesting to determine whether IL-10 pro-
duction by non-CD8+ cell populations is also decreased during
a secondary recall response.
Together our data illustrate distinct patterns of cytokine re-
sponsiveness in naïve and memory T cells that are imposed by
persistent changes in cytokine receptor expression and that
define the functional characteristics of each population. We
demonstrate that a sustained modulation of cytokine re-
sponsiveness is a feature of both murine and human CD8+ T-
cell differentiation, and thus our findings are particularly rele-
vant to the design of medical strategies to manipulate effector
and memory cell function via cytokine signals, such as vacci-
nation or cytokine therapy.
Materials and Methods
Mice and Infections. Vert-X (C57BL/6 IL-10/eGFP) (18), C57BL/6, CD45.1+ con-
genic (B6.SJL-PtprcaPep3b/BoyJ), Il27ra−/− (23), TCRβδ−/− (B6.129P2-
Tcrbtm1MomTcrdtm1Mom/J), and OTI [C57BL/6-Tg(TcraTcrb)1100Mjb/J] mice
were bred and housed at the Trudeau Institute. Animals were kept under
specific pathogen-free conditions in filter-top cages and used at 6–12 wk of
age. Mice were infected intranasally with either Sendai or influenza virus.
Virus strains and doses are given in SI Materials and Methods. All experimental
procedures were approved by the Institutional Animal Care and Use Committee
of the Trudeau Institute and the University of British Columbia.
Tissue Sampling and Flow Cytometry. Details of antibodies used are given in SI
Materials and Methods. Samples were acquired on a FACSCanto or LSRII
cytometer (BD Biosciences) and analyzed with FlowJo software (TreeStar).
Cytokine Stimulation and Phospho-STAT Analysis. To assess cytokine respon-
siveness, cells were labeled with tetramers, stimulated for 15 min at 37 °C with
20 ng/mL recombinant murine IL-6, IL-21, IL-27, or IFNβ (Peprotech), and
Fig. 7. Altered IL-27 responsiveness in CD8+ memory T cells results in re-
duced IL-10 production. (A) Naïve (CD44lo CD62Lhi) and memory (CD44hi
CD62Llo) CD8+ lymphocyte populations were purified from the spleens of
C57BL/6 mice infected with Sendai virus 30–45 d earlier and cultured with
anti-CD3 and anti-CD28 in the presence or absence of recombinant IL-27.
Culture supernatants were harvested after 72 h and analyzed by cytometric
bead array. Each data point represents an individual mouse and both panels
are representative of five mice per group in two independent experiments.
(B) TCR transgenic CD8+ cells were activated and transduced in vitro with
either a gp130-expressing (gp130) or an empty retroviral vector (mock) be-
fore being rested and restimulated in the presence or absence of recombi-
nant IL-27. Supernatants were harvested after 72 h and analyzed by
cytometric bead array. Bars represent mean of triplicate cultures ± SD, and
both panels are representative of three independent experiments.







































immediately fixed and permeabilized using PhosFlow reagents (BD Bio-
sciences). Phosphorylated STAT1 (pY701) and STAT3 (pY705) were detected by
intracellular staining (clones 4a and 4/P-Stat3 respectively; BD Biosciences).
Human PBMC. Cryopreserved human PBMCs were purchased from Cellular
Technology Ltd. Cells were labeled with a Pro5 Recombinant Murine MHC
Pentamer specific for the influenza A M1 epitope (Proimmune), stimulated
for 15 min at 37 °C with 20 ng/mL recombinant human IL-27 (R&D Systems),
and stained for pSTAT1 and pSTAT3 as above. Surface antigens were
assessed using fluorochrome-labeled antibodies against CD8 (clone RPA-T8),
CD19 (HIB19), CD27 (O323), and CD45RA (HI100) (eBioscience).
In Vitro Culture and Retroviral Transduction. Sort-purified naïve or memory
CD8+ T cells were activated in vitro by coculture with live APC, anti-CD3, and
anti-CD28. OTI transduction was performed by infecting activated OTI cells
with a MIG retrovirus. Cells were transferred to medium containing IL-15 to
rest on day 3 after activation, before being restimulated and assayed on
day 7. Details are given in SI Materials and Methods.
Statistical Analysis. Statistical analyses were performed using GraphPad
Prism 5. Significant differences between sample groups were determined
using a Student t test or a one-way analysis of variance with Bonferroni’s
posttest to compare two preselected groups (*P < 0.05; **P < 0.01; ***P <
0.001; n/s, not significant).
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